Entasis Therapeutics (ETTX) News Today → [BUY ALERT] Our #1 A.I. Stock for March (From Behind the Markets) (Ad) Free ETTX Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineHedge Fund and Insider Trading News: D.E. Shaw, Elliott Management, Millennium Management, Marshall Wace LLP, Three Arrows Capital, Entasis Therapeutics Holdings Inc. (ETTX), Gossamer Bio Inc (GOSS), and Moreinsidermonkey.com - July 18 at 6:46 PMmarketbeat.com - July 11 at 6:01 AMEntasis Therapeutics Presents Data on Sulbactam-Durlobactam and ETX0462 at 2022 ASM Microbe Annual Conferencefinance.yahoo.com - June 9 at 1:48 PMEntasis Therapeutics Presents Data on Sulbactam-Durlobactam and ETX0462 at 2022 ASM Microbe Annual Conferencefinance.yahoo.com - June 9 at 1:48 PMINVESTIGATION ALERT: Halper Sadeh LLP Investigates MANT, ETTX, CTEKapnews.com - June 9 at 2:42 AMScott+Scott Attorneys at Law LLP Investigates Innoviva Buyout of Entasis – ETTXapnews.com - June 3 at 5:13 PMSHAREHOLDER NOTICE: Halper Sadeh LLP Investigates ETTX, CDEV, CTEKapnews.com - May 31 at 10:20 AMShort Interest in Entasis Therapeutics Holdings Inc. (NASDAQ:ETTX) Decreases By 35.4%marketbeat.com - May 29 at 4:53 PMBiotech Stock Roundup: ETTX Up on Acquisition Deal, REGN Offers Updatesfinance.yahoo.com - May 25 at 12:02 PMENTASIS ALERT: Bragar Eagel & Squire, P.C. Investigates Merger of ETTX and Encourages Investors to Contact the Firmapnews.com - May 25 at 7:01 AMSHAREHOLDER ALERT: Halper Sadeh LLP Investigates ETTX, CTEK, VSAT, WLL, LHCGapnews.com - May 24 at 3:52 PMAstraZeneca spinout, based in Waltham, acquired at 60% premiumfinance.yahoo.com - May 24 at 3:52 PMInvestor Alert - The M&A Class Action Firm Announces an Investigation of Entasis Therapeutics Holdings Inc. - ETTXbenzinga.com - May 24 at 12:13 AMETTX Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of Entasis Therapeutics Holdings Inc. Is Fair to Shareholdersapnews.com - May 23 at 7:13 PMmarketbeat.com - May 23 at 8:04 AMAntibiotic resistance efforts get a boost as CARB-X gets $370Mfinance.yahoo.com - May 19 at 4:07 PMEntasis Therapeutics Presents Data Highlights from Phase 3 ATTACK Trial at 2022 American Thoracic Society Annual Conferencefinance.yahoo.com - May 17 at 11:57 AMEntasis Therapeutics Presents Data Highlights from Phase 3 ATTACK Trial at 2022 American Thoracic Society Annual Conferencefinance.yahoo.com - May 17 at 11:57 AMEntasis Therapeutics Announces First Quarter 2022 Financial Results and Provides Business Updatefinance.yahoo.com - April 27 at 10:26 AMEntasis Therapeutics Announces First Quarter 2022 Financial Results and Provides Business Updatefinance.yahoo.com - April 27 at 10:26 AMEntasis Therapeutics Presents Efficacy and Safety Data from Landmark Phase 3 ATTACK Trial at ECCMID 2022 Conferencefinance.yahoo.com - April 26 at 9:09 AMEntasis Flat on Databaystreet.ca - April 18 at 1:17 PMEntasis Therapeutics Presents SUL-DUR Topline Data from Phase 3 ATTACK Trial at ECCMID 2022 Conferencefinance.yahoo.com - April 18 at 1:17 PMAlliance Global Partners Downgrades Entasis Therapeutics Hldg to Neutralbenzinga.com - March 16 at 12:09 PMEntasis Therapeutics (NASDAQ:ETTX) Downgraded by Alliance Global Partners to Neutralmarketbeat.com - March 16 at 7:39 AMEntasis Shares Rise After Innoviva Raises Buyout Price to $2 a Sharemarketwatch.com - March 15 at 9:58 AMEntasis Therapeutics (NASDAQ:ETTX) Rating Increased to Buy at Zacks Investment Researchmarketbeat.com - March 8 at 10:21 PMWedbush Downgrades Entasis Therapeutics Hldg to Neutral, Lowers Price Target to $1.8benzinga.com - March 8 at 12:21 PMHC Wainwright & Co. Downgrades Entasis Therapeutics Hldg to Neutral, Lowers Price Target to $1.8benzinga.com - March 4 at 3:50 PMEntasis Therapeutics Announces Year End 2021 Financial Results and Provides Business Updatefinance.yahoo.com - March 3 at 11:00 AMPre-market Movers: MDJH, ELMS, EXC, PYPL, PHAR…nasdaq.com - February 3 at 8:42 PMEntasis Therapeutics Receives Acquisition Proposal from Existing Majority Stockholder Innoviva Inc.finance.yahoo.com - February 2 at 8:04 PMEntasis gains on buyout proposal from Innovivaseekingalpha.com - February 2 at 9:54 AMEntasis Therapeutics Holdings Inc. Common Stock (ETTX)nasdaq.com - January 12 at 8:37 PMEntasis Therapeutics to Participate in H.C. Wainwright BioConnect 2022finance.yahoo.com - January 10 at 9:59 AMIs Entasis Therapeutics Holdings (NASDAQ:ETTX) In A Good Position To Deliver On Growth Plans?nasdaq.com - November 12 at 9:56 AMHow Many Entasis Therapeutics Holdings Inc. (NASDAQ:ETTX) Shares Do Institutions Own?finance.yahoo.com - November 12 at 9:56 AMEntasis Therapeutics Announces Third Quarter 2021 Financial Results and Provides Business Updatefinance.yahoo.com - November 4 at 9:28 AMEntasis Therapeutics to Report Third Quarter 2021 Results and Host Conference Call November 4, 2021finance.yahoo.com - October 28 at 12:46 PMEntasis' (ETTX) Phase III Study on Infection Drug Meets Goalfinance.yahoo.com - October 20 at 2:20 PMEntasis Shares Rally On Positive Data From Drug-Resistant Bacterial Infection Candidatefinance.yahoo.com - October 19 at 1:01 PMZai Lab and Entasis Therapeutics Announce Positive Topline Results for Sulbactam-Durlobactam (SUL-DUR) from Phase 3 ATTACK Trialfinance.yahoo.com - October 19 at 1:01 PMEntasis Therapeutics announces positive topline results for sulbactam-durlobactam (SUL-DUR)apnews.com - October 19 at 8:00 AMBRIEF-Entasis Therapeutics Announces Positive Topline Results For Sulbactam-Durlobactam From Phase 3 Attack Trialmsn.com - October 19 at 1:58 AMEntasis Therapeutics announces positive topline results for sulbactam-durlobactam (SUL-DUR) from Phase 3 ATTACK trialfinance.yahoo.com - October 18 at 8:57 PMmarketbeat.com - October 18 at 4:04 PMEntasis Therapeutics to Participate in the Cantor Fitzgerald Virtual Global Healthcare Conferencefinance.yahoo.com - September 23 at 8:27 PMEntasis Therapeutics to Participate in the Cantor Fitzgerald Virtual Global Healthcare Conferencebenzinga.com - September 23 at 4:12 PMModerna Highlights New Clinical Data on its COVID-19 Vaccinenz.finance.yahoo.com - September 17 at 12:42 AMWhy Are Entasis Therapeutics Shares Moving Higher On Thursday?msn.com - September 16 at 7:42 PM Get Entasis Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ETTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Did you make $29,000 two days with AI options trades? (Ad)What if it was possible to find options trades on autopilot… Using A.I. to find the ones with the highest profit potential… And nearly perfect win rates… You can grab your free copy of my "Ultimate Guide to A.I. Options Trading" by clicking the link below: Click Here To Get Your Free Copy ETTX Media Mentions By Week ETTX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ETTX News Sentiment▼0.000.63▲Average Medical News Sentiment ETTX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ETTX Articles This Week▼00▲ETTX Articles Average Week Get Entasis Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ETTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: DiaMedica Therapeutics News Today Reviva Pharmaceuticals News Today Lantern Pharma News Today Cartesian Therapeutics News Today Vincerx Pharma News Today Anixa Biosciences News Today Oramed Pharmaceuticals News Today Adagene News Today IO Biotech News Today Eton Pharmaceuticals News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ETTX) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the Markets“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Entasis Therapeutics Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.